Market News

Telesis Bio Earnings Recap: A Disappointing Q4 2023 Performance

by Ron Finklestien

Published On: March 29, 2024 1:08 am

Telesis Bio Falls Short on Earnings and Revenue Targets

TBIO stock - TBIO Stock Earnings: Telesis Bio Misses EPS, Misses Revenue for Q4 2023

Source: iQoncept / Shutterstock

Telesis Bio (NASDAQ:TBIO) has recently disclosed its financial results for the fourth quarter of 2023.

Telesis Bio recorded earnings per share of -23 cents, falling short of the estimated -22 cents by analysts.
The company generated revenue of $6.98 million, slightly missing the anticipated $7.00 million.

InvestorPlace Earnings relies on TradeSmith data to create automated coverage of quarterly earnings reports. The tool summarizes crucial details such as earnings per share and revenue, alongside how a company compares to analyst forecasts. These articles are generated without human intervention to promptly deliver the latest figures to our readers. To address any concerns or inaccuracies, reach out to us at [email protected].

Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/03/tbio-stock-earnings-telesis-bio-for-q4-of-2023/.